Added to YB: 2026-10-14
Pitch date: 2026-10-11
009300.KQ [bullish]
Sam-A Pharm. Co., Ltd
-1.57%
current return
Author Info
No bio for this author
Company Info
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines.
Market Cap
KRW 85.3B
Pitch Price
KRW 14.1K
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.65
P/E
8.09
EV/Sales
-0.08
Sector
Pharmaceuticals
Category
value
Negative EV, Net-Net, Profitable, 6% Dividend - Sam-A Pharm. Co.
009300.KQ: Sam-A Pharm is effectively a fixed-income portfolio with a profitable prescription-drug manufacturer attached for free: its KRW 85.3B market cap equals 0.53x adjusted NCAV, with KRW 148B of cash and investments, no debt and a 6.1% dividend yield. Risks include compressed drug margins, undisclosed bond issuers and ratings, roughly KRW 18B of U.S. commercial-property exposure, potential dilution and no treasury-share cancellation through at least 2027.
Read full article (3 min)